The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Biogen Inc

Nasdaq: BIIB
Last

(U.S.) $279.81

Today's change-0.51 -0.18%
Updated June 26 4:15 PM EDT. Delayed by at least 15 minutes.
 

Biogen Inc

Nasdaq: BIIB
Last

(U.S.) $279.81

Today's change-0.51 -0.18%
Updated June 26 4:15 PM EDT. Delayed by at least 15 minutes.

Biogen Inc down (U.S.)$0.51

Biogen Inc closed lower Monday, dropping (U.S.)$0.51 or 0.18% to (U.S.)$279.81. Over the last five days, shares have gained 7.40%, but are currently unchanged over the last year to date. Shares have outperformed the S&P 500 by 2.46% during the last year.

Key company metrics

  • Open(U.S.) $281.74
  • Previous close(U.S.) $280.32
  • High(U.S.) $282.89
  • Low(U.S.) $277.64
  • Bid / Ask(U.S.) $279.81 / (U.S.) $283.00
  • YTD % change-1.33%
  • Volume1,279,545
  • Average volume (10-day)2,156,729
  • Average volume (1-month)1,684,658
  • Average volume (3-month)1,630,509
  • 52-week range(U.S.) $223.02 to (U.S.) $333.65
  • Beta0.79
  • Trailing P/E17.55×
  • P/E 1 year forward13.70×
  • Forward PEG1.95×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $15.95
Updated June 26 4:15 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.02%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue2,8112,8722,9562,894
Total other revenue--------
Total revenue2,8112,8722,9562,894
Gross profit2,4262,4942,5392,524
Total cost of revenue385379417370
Total operating expense1,7861,9861,5311,434
Selling / general / administrative499496463492
Research & development423534529473
Depreciation / amortization44910410093
Interest expense (income), net operating--------
Unusual expense (income)104631811
Other operating expenses, total21115-6
Operating income1,0248861,4251,461
Interest income (expense), net non-operating-63-65-66-66
Gain (loss) on sale of assets--------
Other--------
Income before tax9878381,3671,402
Income after tax7486481,0301,048
Income tax, total239190337354
Net income7486491,0331,050
Total adjustments to net income--------
Net income before extra. items7486491,0331,050
Minority interest0131
Equity in affiliates0000
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items7486491,0331,050
Inc. avail. to common incl. extra. items7486491,0331,050
Diluted net income7486491,0331,050
Dilution adjustment--------
Diluted weighted average shares216217219219
Diluted EPS excluding extraordinary itemsvalue per share3.462.994.714.78
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share3.504.644.774.82